| | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $814,373 ) |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 3 | 10/31/2024 | NON-COMPETING CONTINUATION | $814,373 |
|
| Issue Date FY: 2024 ( Subtotal = $849,858 ) |
| | 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 2 | 11/22/2023 | NON-COMPETING CONTINUATION | $764,872 |
| | 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 2 | 5/13/2024 | NON-COMPETING CONTINUATION | $84,986 |
|
| Issue Date FY: 2023 ( Subtotal = $893,464 ) |
| | 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 1 | 11/2/2022 | NEW | $893,464 |
| | 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 1 | 12/8/2022 | NEW | $0 |
|
|
